Ensysce Biosciences
(NASDAQ) ENSC
Ensysce Biosciences Financials at a Glance
Market Cap
$4.31M
Revenue (TTM)
$5.07M
Net Income (TTM)
$10.18M
EPS (TTM)
$-4.22
P/E Ratio
-0.11
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.48
Volume
183,423.649
Open
$0.49
Price
$0.48
Volume
183,423.649
Open
$0.49
Previous Close
$0.46
Daily Range
$0.46 - $0.50
52-Week Range
$0.31 - $4.85
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.48
Volume
183,423.649
Open
$0.49
Previous Close
$0.46
Daily Range
$0.46 - $0.50
52-Week Range
$0.31 - $4.85
ENSC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ensysce Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
D. Lynn Kirkpatrick, PhD
Website
www.ensysce.comHeadquarters
La Jolla, CA 92037, US
ENSC Financials
Key Financial Metrics (TTM)
Gross Margin
-33%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-294%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-9.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.31M
Shares Outstanding
9.28M
Volume
183.42K
Short Interest
0.00%
Avg. Volume
6.03M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$10.24M
EBITDA
$10.15M
Operating Cash Flow
$7.81T
Capital Expenditure
$0.00
Free Cash Flow
$7.81T
Cash & ST Invst.
$4.31T
Total Debt
$306.71B
Ensysce Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.88M
+44.4%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$4.31M
N/A
Market Cap/Employee
$615.64K
N/A
Employees
7
N/A
Net Income
$2.77M
+22.4%
EBITDA
$2.76M
N/A
Quarterly Fundamentals
Net Cash
$4.00T
+125097535.7%
Accounts Receivable
$420.35K
+238.7%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$306.71B
+101673307.1%
Return on Assets
-1.37%
N/A
Return on Invested Capital
-3.55%
N/A
Free Cash Flow
$1.53M
-99.7%
Operating Cash Flow
$1.53M
-99.7%